As of 2026-10-01, the Intrinsic Value of Vincerx Pharma Inc (VINC) is -170.33 USD. This VINC valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.10 USD, the upside of Vincerx Pharma Inc is -170,427.00%.
Based on its market price of 0.10 USD and our intrinsic valuation, Vincerx Pharma Inc (VINC) is overvalued by 170,427.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -170.33 - -170.33 | -170.33 | -170,427.00% |
| P/E | (371.31) - (739.22) | (570.60) | -570696.1% |
| DDM - Stable | (220.02) - (565.85) | (392.94) | -393035.7% |
| DDM - Multi | (246.85) - (507.88) | (333.74) | -333839.0% |
| Market Cap (mil) | 0.07 |
| Beta | -1.01 |
| Outstanding shares (mil) | 0.66 |
| Enterprise Value (mil) | -4.37 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.13% |
| Cost of Debt | 5.00% |
| WACC | 7.90% |